You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

red cell metabolism

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 10, 2020

Neuroblastoma, High-Risk Trial in New York (cyclophosphamide, NK cells, hu3F8)

Active, not recruiting
  • Neuroblastoma
  • High-Risk
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 14, 2022

Lung Cancer Trial in Aurora (Bronchoscopies, Sputum Sample, Venipuncture)

Recruiting
  • Lung Cancer
  • Bronchoscopies
  • +2 more
  • Aurora, Colorado
  • +1 more
Oct 18, 2021

Smoking Cessation, HIV Trial in Boston, Guangxi (Sessions with a trained counselor, Cell phone messages, Offered nicotine

Enrolling by invitation
  • Smoking Cessation
  • HIV Infections
  • Sessions with a trained counselor
  • +3 more
  • Boston, Massachusetts
  • +1 more
Mar 3, 2022

COVID-19 Pneumonia Trial in Wenzhou (Extracellular Vesicles from Mesenchymal Stem Cells)

Recruiting
  • COVID-19 Pneumonia
  • Extracellular Vesicles from Mesenchymal Stem Cells
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Mar 27, 2023

Prognostic Value of Protein IMP3 Expression in Cervical Cancer

Active, not recruiting
  • Cervical Carcinoma
  • immunohistochemical analysis with murine monoclonal antihuman antibodies IMP3
  • (no location specified)
Jan 5, 2022

Acute Lymphoblastic Leukemia Trial (GRASPA)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 21, 2021

Whole Blood From Active Non-Small Cell Lung Cancer Supplemental

Recruiting
  • Non Small Cell Lung Cancer
  • Specimen sample
  • Waltham, Massachusetts
    Sanguine Biosciences
Dec 28, 2022

Diabetes, Type 2, Hyperglycemia, Perioperative/Postoperative Complications Trial (Metformin, Salsalate)

Withdrawn
  • Diabetes Mellitus, Type 2
  • +2 more
  • (no location specified)
Jan 12, 2023

Vulvar Cancer Trial in Vancouver (Re-excision)

Not yet recruiting
  • Vulvar Cancer
  • Re-excision
  • Vancouver, British Columbia, Canada
    BC Cancer - Vancouver Centre
Oct 8, 2022

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Head and Neck Squamous Cell Carcinoma, Oral Mucositis Trial in Korea, Republic of, United States (MIT-001 plus CCRT)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Oral Mucositis
  • MIT-001 plus CCRT
  • Gilbert, Arizona
  • +14 more
Jan 27, 2022

Utility of Primary Glioblastoma Cell Lines

Recruiting
  • Tumor
  • Brain Tumor
    • Pozzilli, IS, Italy
      Neuromed IRCCS
    Apr 9, 2021

    Giant Cell Arteritis Trial in France (color Doppler ultrasound and TAB in case of CDU negative)

    Completed
    • Giant Cell Arteritis
    • color Doppler ultrasound and TAB in case of CDU negative
    • Angoulême, France
    • +5 more
    Apr 19, 2022

    Renal Cancer, Metastases, PSMA PET Trial in Xi'an (PSMA PET)

    Recruiting
    • Renal Cancer
    • +2 more
    • PSMA PET
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Jul 22, 2021

    Hydroxyurea in Sickle Cell Anemia (The BABY HUG Follow-up Study)

    Completed
    Has Results
    • Anemia, Sickle Cell
    • Birmingham, Alabama
    • +13 more
    Aug 10, 2020

    Healthy Adult Subjects Trial in Hefei (Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL), Test drug (T2):

    Not yet recruiting
    • Healthy Adult Subjects
    • Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)
    • +2 more
    • Hefei, Anhui, China
      The Second Hospital of Anhui Medical University
    Jun 14, 2023

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +3 more
    • Scottsdale, Arizona
    • +2 more
    Jan 4, 2023

    Metastatic NSCLC, Recurrent NSCLC, Advanced Non-Small Cell Squamous Lung Cancer Trial in Nanjing (Sintilimab + Anlotinib +

    Recruiting
    • Metastatic NSCLC
    • +2 more
    • Sintilimab + Anlotinib + Pemetrexed + Cisplatin or Carboplatin
    • Sintilimab + Anlotinib + Albumin Paclitaxel + Carboplatin
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Aug 10, 2021

    HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple

    Recruiting
    • HER2-negative Early Breast Cancer
    • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
    • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
    • Beijing, China
      Peking University People's Hospital
    Mar 27, 2022

    Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

    Completed
    Has Results
    • Indolent Non-Hodgkin's Lymphoma
    • +2 more
    • Huntsville, Alabama
    • +10 more
    Feb 22, 2021

    X-linked Adrenoleukodystrophy Trial in Leipzig (SMART-ALD, Waiting list)

    Recruiting
    • X-linked Adrenoleukodystrophy
    • SMART-ALD
    • Waiting list
    • Leipzig, Saxony, Germany
    • +1 more
    Aug 16, 2022

    Serum Raman Spectroscopy Intelligent System for Diagnosis of

    Recruiting
    • Prostate Cancer
    • Serum Raman spectroscopy intelligent diagnostic system
    • Shanghai, China
      RenJi hospital, school of Medicine, Shanghai Jiao Tong Universit
    May 3, 2023

    MDD, Alcohol Use Disorder Trial in Harlingen (allogeneic human mesenchymal stem cells (allo-hMSCs), Placebo)

    Active, not recruiting
    • Major Depressive Disorder
    • Alcohol Use Disorder
    • allogeneic human mesenchymal stem cells (allo-hMSCs)
    • Placebo
    • Harlingen, Texas
      University of Texas Rio Grande Valley School of Medicine
    Nov 14, 2022

    CemiplimAb Survivorship Epidemiology

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Basal Cell Carcinoma
    • Huntsville, Alabama
    • +52 more
    Dec 14, 2022